Ra. Rogers et Je. Riviere, PHARMACOLOGICAL MODULATION OF THE CUTANEOUS VASCULATURE IN THE ISOLATED-PERFUSED PORCINE SKIN FLAP, Journal of pharmaceutical sciences, 83(12), 1994, pp. 1682-1689
The isolated perfused porcine skin flap (IPPSF), an ex vivo model syst
em used in cutaneous toxicology and pharmacology, is capable of assess
ing the percutaneous absorption of vasoactive compounds. However, the
Vascular responses of the IPPSF to classical pharmacologic agents have
not been calibrated. The ability of acetylcholine, nitroglycerin, tol
azoline, and norepinephrine to affect Vasculature resistance and gluco
se utilization was investigated in the IPPSF. Norepinephrine infusions
between 10(-7) and 10(-5) M increased Vascular resistance in a dose-d
ependent manner; half-maximal (EC(50)) and maximal responses occurred
at 3.18 x 10(-6) and 10(-5) M, respectively. In non-preconstricted fla
ps, neither acetylcholine, nitroglycerin, nor tolazoline vasodilated t
he IPPSF; however, acetylcholine, nitroglycerin, and tolazoline each l
owered Vascular resistance in a dose-dependent manner in norepinephrin
e-preconstricted flaps. Maximal relaxation was induced at 10(-4), 10(-
6), and 5 x 10(-5) M, by tolazoline, acetylcholine, and nitroglycerin,
respectively, whereas the EG(50) values were 2.88 x 10(-7), 1.35 x 10
(-8), and 1.72 x 10(-7) M, respectively. In flaps pretreated with nore
pinephrine and methylene blue (a potential blocker of edothelium-deriv
ed relaxing factor), no concentration of acetylcholine, and only the h
ighest concentration of nitroglycerin, lowered Vascular resistance. in
non-preconstricted flaps, glucose utilization decreased in norepineph
rine-infused flaps, increased in nitroglycerin- and tolazoline-infused
flaps, and was biphasic in acetylcholine-infused flaps. These results
indicate that the IPPSF responds to pharmacologic agents in a manner
similar to classic in vitro and in vivo models. Thus, the IPPSF would
be a relevant model for investigating the delivery and/or toxicity of
pharmacologically active compounds.